Migraine in children population - systemic review
DOI:
https://doi.org/10.12775/JEHS.2022.12.03.024Keywords
migraine, children, diagnosis, treatmentAbstract
Introduction and objective: Migraine constitutes the main reason for acute and recurrent headache among children globally. It is a primary headache syndrome that affects from 3 up to 10% of paediatric population. The frequency of migraine increases with age up to puberty. The aim of this study is to systemize recent knowledge about migraine in children. The information used in the presented analysis was obtained by searching academic research databases: Google Scholar and PubMed.
An abbreviated description of the state of knowledge: The exact pathogenesis of migraine remains unknown, but involvement of nervous system, cardiovascular system, genetic predisposition and environmental factors are considered in the development of disease. Symptoms of migraine vary between individuals and can be wide-ranging. They may resemble disorders such as tension headache, cluster headache, epilepsy, brain tumour or ischemic stroke. The diagnostic process is based on anamnesis, and may therefore be challenging in children because of difficulties related to communication. Symptom-relieving therapy of migraine is well-established in contrast to pharmacological prophylactic treatment which is not sufficiently evidence-based.
Summary: Migraine remains a global problem in the paediatric population. The condition is associated not only with physical pain, but also it leads to many long-term complications such as emotional problems and social disruption. Lack of safe and effective preventive medical therapies is a driving factor to improve trials of migraine treatment in the future.
References
Peters GL. Migraine overview and summary of current and emerging treatment options. Am J Manag Care 2019;25(2):23-34.
de Boer I, van den Maagdenberg AMJM, Terwindt GM. Advance in genetics of migraine. Curr Opin Neurol 2019;32(3):413-421. doi:10.1097/WCO.0000000000000687.
Youssef PE, Mack KJ. Episodic and chronic migraine in children. Dev Med Child Neurol 2020;62(1):34-41. doi:10.1111/dmcn.14338.
Barnes NP. Migraine headache in children. BMJ Clin Evid 2015:0318.
Headache Classification Committee of the International Headache Society (IHS). The International classification of headache disorders, 3rd edition. Cephalalgia 2018; 33: 629–808. doi: 10.1177/0333102413485658.
Hershey AD. Current approaches to the diagnosis and management of paediatric migraine. The Lancet Neurology 2010;9(2):190–204. doi: 10.1016/S1474-4422(09)70303-5.
Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev 2016;4(4):CD005220. doi: 10.1002/14651858.CD005220.pub2.
Blanda M, Rench T, Gerson LW, et al. Intranasal lidocaine for the treatment of migraine headache: a randomized, controlled trial. Acad Emerg Med 2001;8(4):337-342. doi: 10.1111/j.1553-2712.2001.tb02111.x.
El-Metwally A, Toivola P, AlAhmary K, et al. The Epidemiology of Migraine Headache in Arab Countries: A Systematic Review. Scientific World Journal 2020:4790254. doi: 10.1155/2020/4790254.
Split W, Neuman W. Epidemiology of migraine among students from randomly selected secondary schools in Lodz. Headache 1999;39:494–501. doi:10.1046/j.1526-4610.1999.3907494.x.
Santinello M, Vieno A, De Vogli R. Primary headache in Italian early adolescents: the role of perceived teacher unfairness. Headache 2009;49:366–74. doi:10.1111/j.1526-4610.2008.01208.x.
Lee LH, Olness KN. Clinical and demographic characteristics of migraine in urban children. Headache. 1997;37(5):269-76. doi: 10.1046/j.1526-4610.1997.3705269.x.
Pavlovic JM, Buse DC, Sollars CM, et al. Trigger factors and premonitory features of migraine attacks: summary of studies. Headache. 2014;54(10):1670-1679. doi: 10.1111/head.12468.
Gross EC, Lisicki, M, Fischer D, et al. The metabolic face of migraine - from pathophysiology to treatment. Nature Reviews Neurology. 2019;15(11):627-643. doi:10.1038/s41582-019-0255-4.
Cokyaman T, Aylanc H. Evaluation of the diagnostic value of clinical characteristics and situations associated with primary headache in children: International classification of headache Disorders-3 edition. Clin Neurol Neurosurg 2020;196:106039. doi:10.1016/j.clineuro.2020.106039.
Eigenbrodt AK, Ashina H, Khan S, et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol 2021;17(8):501–514. doi:10.1038/s41582-021-00509-5.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33(9):629-808. doi:10.1177/0333102413485658.
Vogler K, Gren C, Debes NM, et al. Diagnostik og behandling af migræne hos børn og unge. Ugeskr Laeger 2018;180(10):V06170484.
Straube A, Andreou A. Primary headaches during lifespan. J Headache Pain 2019;20(1):71. doi:10.1186/s10194-019-0985-0.
Klausen SH, Rønde G, Tornøe B, et al. Nonpharmacological Interventions Addressing Pain, Sleep, and Quality of Life in Children and Adolescents with Primary Headache: A Systematic Review. J Pain Res 2019;12:3437-3459. doi:10.2147/JPR.S216807.
Gazerani P. Migraine and Mood in Children. Behav Sci (Basel) 2021;11(4):52. doi:10.3390/bs11040052.
Raucci U, Della Vecchia N, Ossella C, et al. Management of Childhood Headache in the Emergency Department. Review of the Literature. Front Neurol 2019;10:886. doi:10.3389/fneur.2019.00886.
Shapiro HFJ, Lebel A. Pediatric Episodic Migraine with Aura: A Unique Entity?. Children (Basel) 2021;8(3):228. doi:10.3390/children8030228.
Karsan N, Prabhakar P, Goadsby PJ. Premonitory Symptoms of Migraine in Childhood and Adolescence. Curr Pain Headache Rep 2017;21(7):34. doi:10.1007/s11916-017-0631-y.
Lenglart L, Caula C, Moulding T, et al. Brain to Belly: Abdominal Variants of Migraine and Functional Abdominal Pain Disorders Associated With Migraine. J Neurogastroenterol Motil 2021;27(4):482-494. doi:10.5056/jnm20290.
Li BUK. Managing cyclic vomiting syndrome in children: beyond the guidelines. Eur J Pediatr 2018;177(10):1435-1442. doi:10.1007/s00431-018-3218-7.
Mani J, Madani S. Pediatric abdominal migraine: current perspectives on a lesser known entity. Pediatric Health Med Ther 2018;9:47-58. doi:10.2147/PHMT.S127210.
Albers L, von Kries R, Straube A, et al. Do pre-school episodic syndromes predict migraine in primary school children? A retrospective cohort study on health care data. Cephalalgia 2019; 39(4):497-503. doi:10.1177/0333102418791820.
Lewis D, Ashwal S, Hershey A, et al. American Academy of Neurology Quality Standards Subcommittee; Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 2004;63(12):2215–2224. doi: 10.1212/01.wnl.0000147332.41993.90.
Teleanu RI, Vladacenco O, Teleanu DM, et al. Treatment of Pediatric Migraine: a Review. Maedica (Bucur) 2016;11(2):136-143.
O'Brien HL, Kabbouche MA, Hershey AD. Treatment of acute migraine in the pediatric population. Curr Treat Options Neurol 2010;12(3):178-185. doi:10.1007/s11940-010-0069-6.
O'Brien HL, Kabbouche MA, Hershey AD. Treating pediatric migraine: an expert opinion. Expert Opin Pharmacother 2012;13(7):959-966. doi:10.1517/14656566.2012.677434.
O'Brien HL, Kabbouche MA, Kacperski J, et al. Treatment of pediatric migraine. Curr Treat Options Neurol 2015;17(1):326. doi:10.1007/s11940-014-0326-1.
Puledda F, Shields K. Non-Pharmacological Approaches for Migraine. Neurotherapeutics 2018;15(2):336-345. doi:10.1007/s13311-018-0623-6.
Papetti L, Ursitti F, Moavero R, et al. Prophylactic Treatment of Pediatric Migraine: Is There Anything New in the Last Decade?. Front Neurol 2019;10:771. doi:10.3389/fneur.2019.00771.
Locher C, Kossowsky J, Koechlin H, et al. Efficacy, Safety, and Acceptability of Pharmacologic Treatments for Pediatric Migraine Prophylaxis: A Systematic Review and Network Meta-analysis. JAMA Pediatr 2020;174(4):341-349. doi:10.1001/jamapediatrics.2019.5856.
Faber AJ, Lagman-Bartolome AM, Rajapakse T. Drugs for the acute treatment of migraine in children and adolescents. Paediatr Child Health 2017;22(8):454-458. doi:10.1093/pch/pxx170.
Fliciński J, Żarowski M, Steinborn B. The new classification of International Headache Society. The differences and similarities between the ICHD-3 beta and the ICHD-2. Neurol Dziec 2014;23(46):39-44.
Dao JM, Qubty W. Headache Diagnosis in Children and Adolescents. Curr Pain Headache Rep 2018;22(3):17. doi:10.1007/s11916-018-0675-7.
Tavasoli A, Aghamohammadpoor M, Taghibeigi M. Migraine and tension-type headache in children and adolescents presenting to neurology clinics. Iran J Pediatr 2013;23(5):536-540.
Chochowska M, Klonowska J, Ogrodowczyk R, et al. Tension headache and myofascial pain syndrome. Part I. Classification, pathogenesis, diagnostic criteria. Hygeia Public Health 2015;50(2):283-287.
Vollesen AL, Benemei S, Cortese F, et al. Migraine and cluster headache - the common link. J Headache Pain 2018;19(1):89. doi:10.1186/s10194-018-0909-4.
Genizi J, Bugdnoskya V, Aboud A, et al. Migraine and Tension-Type Headache Among Children and Adolescents: Application of International Headache Society Criteria in a Clinical Setting. J Child Neurol 2021;36(8):618-624. doi:10.1177/0883073820988417.
Mackay MT, Lee M, Yock-Corrales A, et al. Differentiating arterial ischaemic stroke from migraine in the paediatric emergency department. Dev Med Child Neurol 2018;60(11):1117-1122. doi:10.1111/dmcn.13772.
Agostoni E, Rigamonti A. Migraine and cerebrovascular disease. Neurol Sci 2007;28(2):156-160. doi:10.1007/s10072-007-0770-8.
Jurkiewicz MT, Vossough A, Pollock AN. An Important Pediatric Stroke Mimic: Hemiplegic Migraine. Can J Neurol Sci 2020;47(2):235-236. doi:10.1017/cjn.2020.6.
Oakley CB, Kossoff EH. Migraine and epilepsy in the pediatric population. Curr Pain Headache Rep 2014;18(3):402. doi:10.1007/s11916-013-0402-3.
Kasteleijn-Nolst Trenité D, Parisi P. Migraine in the borderland of epilepsy: "migralepsy" an overlapping syndrome of children and adults?. Epilepsia 2012;53(7):20-25. doi:10.1111/j.1528-1167.2012.03711.x.
Khan RB, Merchant TE, Boop FA, et al. Headaches in children with craniopharyngioma. J Child Neurol 2013;28(12):1622-1625. doi:10.1177/0883073812464817.
Evans RW. Migraine mimics. Headache 2015;55(2):313-322. doi:10.1111/head.12518.
Spiri D, Rinaldi VE, Titomanlio L. Pediatric migraine and episodic syndromes that may be associated with migraine. Ital J Pediatr 2014;40:92. doi:10.1186/s13052-014-0092-4.
Orr SL, Kabbouche MA, O'Brien HL, et al. Paediatric migraine: evidence-based management and future directions. Nat Rev Neurol 2018;14(9):515-527. doi:10.1038/s41582-018-0042-7.
Kroon Van Diest AM, Ernst MM, Slater S, et al. Similarities and Differences Between Migraine in Children and Adults: Presentation, Disability, and Response to Treatment. Curr Pain Headache Rep 2017;21(12):48. doi:10.1007/s11916-017-0648-2.
Greene KA, Gentile CP, Szperka CL, et al. Calcitonin Gene-Related Peptide Monoclonal Antibody Use for the Preventive Treatment of Refractory Headache Disorders in Adolescents. Pediatr Neurol 2021;114:62-67. doi:10.1016/j.pediatrneurol.2020.09.014.
Dallavalle G, Pezzotti E, Provenzi L, et al. Migraine Symptoms Improvement During the COVID-19 Lockdown in a Cohort of Children and Adolescents. Front Neurol 2020;11:579047. doi:10.3389/fneur.2020.579047.
Papetti L, Alaimo Di Loro P, Tarantino S, et al. I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children. Cephalalgia 2020;40(13):1459-1473. doi:10.1177/0333102420965139.
Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol 2018;17(2):174-182. doi:10.1016/S1474-4422(17)30435-0.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Małgorzata Wieteska, Dominik Maj, Karolina Gendek, Weronika Bąk, Magdalena Chrościńska-Krawczyk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 431
Number of citations: 0
